India Disposable Syringes Market Research Report, 2030

From busy outpatient clinics in Delhi to rural health camps deep in the interiors of Bihar, the journey of the disposable syringe in India has been a silent but revolutionary force in transforming the nation's healthcare delivery, one injection at a time. Before the 1980s, most medical practitioners across India relied on glass syringes that were reused repeatedly, often with substandard sterilization practices, especially in primary health centers with limited infrastructure. This posed severe risks of spreading infections such as HIV and hepatitis. The turning point came when India faced rising concerns about unsafe injection practices during nationwide immunization drives and started importing disposable syringes, followed by local production in the 1990s. The government and public health experts soon pushed for single-use syringes in national programs like the Universal Immunization Programme (UIP) and the Revised National Tuberculosis Control Program (RNTCP). A disposable syringe is a pre-sterilized, single-use plastic instrument used for injecting or withdrawing fluids, designed with a plunger, barrel, and hypodermic needle. It ensures patient safety by preventing the reuse of needles, thus avoiding cross-infection. In India, these syringes are used across government hospitals, private clinics, veterinary services, community health campaigns, and self-use by patients with diabetes or hormone therapy. Local manufacturers introduced a variety of syringes such as fixed-needle, auto-disable, and luer-lock types to meet the diverse needs of urban, rural, and remote regions. Yet, challenges persist. One issue is the penetration of cheap, substandard syringes in the unregulated private medical market, particularly in tier-2 and tier-3 cities. Another is waste management millions of used syringes pile up with inadequate disposal protocols, often ending up in general waste or being repurposed illegally. There's also a lack of awareness among rural practitioners who may still reuse syringes out of cost-saving habits. Furthermore, logistical issues in maintaining consistent supply chains to remote areas during emergencies affect syringe availability. According to the research report "India Disposable Syringe Market Research Report, 2030," published by Actual Market Research, the India Disposable Syringe Market is anticipated to grow at more than 9.28% CAGR from 2025 to 2030. India’s disposable syringe market is largely driven by the government’s aggressive healthcare campaigns, such as mass immunization for polio, COVID-19, and hepatitis, along with the growing burden of non-communicable diseases like diabetes and arthritis that require frequent injections. The rise of insurance-based healthcare under Ayushman Bharat and increased awareness around infection control has also accelerated adoption. Recent developments include the introduction of auto-disable syringes for all vaccination programs and expansion of production facilities under the Make in India initiative, ensuring localized supply and cost efficiency. Major players dominating the Indian market include Hindustan Syringes & Medical Devices (HMD), Becton Dickinson India, and Poly Medicure Ltd., which offer a wide array of products from basic 2 ml disposable syringes to specialty prefilled devices for chemotherapy and insulin therapy. These companies cater to public tenders and private hospitals alike, focusing on affordability, bulk packaging, and safety-enhancing designs. Opportunities exist in tapping the rural health segment with low-cost safety syringes, as well as in exporting high-volume products to other developing countries through South-South collaborations. Compliance is regulated by the Central Drugs Standard Control Organization (CDSCO), along with adherence to WHO guidelines for safe injection practices and ISO 13485 standards. These frameworks ensure that syringes meet quality benchmarks for use in national and international health programs. Market trends now include a shift toward eco-friendly, biodegradable syringe materials to reduce biomedical waste, growing popularity of single-use prefilled syringes in self-care treatments, and the digitization of cold chain and inventory systems to streamline distribution during mass health campaigns. These trends highlight India's push toward balancing scale with sustainability, ensuring every injection is safe, traceable, and accessible to all layers of society.

What's Inside a Actual Market Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Conventional syringes, typically composed of a transparent plastic barrel, plunger, and a single-use needle, have been the backbone of medical injections in India for decades. They remain popular due to their affordability and simplicity, especially in rural and semi-urban healthcare facilities where cost constraints play a significant role in procurement decisions. However, India has faced persistent challenges related to the reuse of syringes and needle-stick injuries, which contribute to the spread of bloodborne diseases like hepatitis B, hepatitis C, and HIV. To address these concerns, safety syringes have been increasingly introduced, featuring advanced safety mechanisms such as retractable needles, needle shields, and auto-disable functions that prevent reuse and accidental injuries. These innovations have gained traction particularly in urban hospitals, government immunization programs, and private healthcare settings, supported by regulatory efforts and public health initiatives aimed at improving patient and healthcare worker safety. Despite higher costs, safety syringes are gradually being adopted as India seeks to modernize its healthcare infrastructure and enhance infection control practices. The coexistence of conventional and safety syringes highlights India’s ongoing transition as it balances affordability, accessibility, and the urgent need to protect its population from avoidable medical risks through improved syringe technologies. Immunization injections drive substantial syringe demand, fueled by India’s extensive vaccination campaigns targeting infectious diseases such as polio, tuberculosis, measles, hepatitis B, and more recently, the COVID-19 pandemic. These mass immunization efforts require syringes that provide reliable sterility, precise dosage delivery, and ease of handling, especially by frontline healthcare workers operating in diverse environments ranging from urban hospitals to remote rural outreach centers. The prevention of needle reuse and cross-contamination remains a critical priority in these large-scale vaccination programs, leading to a significant preference for auto-disable and safety syringes that help reduce the transmission of bloodborne infections. Therapeutic injections also represent a vital segment, encompassing the administration of medications for chronic conditions such as diabetes, cancer, arthritis, and infectious diseases. With India’s rising population and increasing burden of non-communicable diseases, the demand for therapeutic syringes is growing rapidly. Prefilled syringes and other user-friendly designs are increasingly favored to improve patient compliance, especially for self-administration at home, as they offer benefits such as accurate dosing, reduced preparation errors, and enhanced convenience. These dual applications illustrate the indispensable role of disposable syringes in India’s healthcare system, where they contribute significantly to both preventive healthcare and ongoing disease management amid the challenges of scale, access, and safety. Hospitals, ranging from large urban medical centers to smaller rural clinics, are the predominant users, relying on disposable syringes for immunizations, surgeries, anesthesia administration, and routine therapeutic injections. The need for stringent infection control and patient safety measures compels hospitals to increasingly adopt safety syringes, although cost factors still influence procurement choices in resource-limited settings. Diagnostic laboratories utilize disposable syringes primarily for precise blood and sample collection, essential for accurate diagnosis, monitoring of diseases, and research. Maintaining sterility and minimizing contamination in these settings are critical for reliable outcomes. Blood banks depend on disposable syringes to ensure safe blood collection and transfusion processes, where contamination prevention directly impacts donor and recipient safety. Additionally, the pharmaceutical industry in India is progressively incorporating prefilled syringes into clinical trials and commercial drug delivery, appreciating their advantages in dosing accuracy, sterility, and ease of use. This segment is expected to expand further as biopharmaceutical development grows in the country. Collectively, these diverse end-user groups influence continuous advancements in syringe design, safety features, and material quality, reflecting India’s commitment to improving healthcare outcomes through safer, more efficient injection devices that address the unique challenges posed by its vast and varied healthcare environment.

Make this report your own

We're excited to discuss your needs and our solutions. Let's schedule a call.

Ask an Expert

Nikita Jabrela

Business Development Manager

Considered in this report • Historic Year: 2019 • Base year: 2024 • Estimated year: 2025 • Forecast year: 2030 Aspects covered in this report • Disposable Syringes Market with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By Type • Conventional Syringes • Safety Syringes

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

By Application • Immunization Injections • Therapeutic Injections By End User • Hospitals • Diagnostic Laboratories • Blood Banks • Others (Pharmaceutical Industry (B2B) (Prefilled Syringes)) The approach of the report: This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analyzing the government generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources. Intended audience This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to this industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.